What is Esperion Therapeutics's change in AP?

Esperion Therapeutics (ESPR) reported change in AP of $3.34M in Q1 2026.

How has Esperion Therapeutics's change in AP changed year-over-year?

Esperion Therapeutics's change in AP decreased by 88.0% year-over-year, from $27.84M to $3.34M.

What is the long-term trend for Esperion Therapeutics's change in AP?

Over 2 years (2021 to 2023), Esperion Therapeutics's change in AP has grown at a -49.6% compound annual growth rate (CAGR), from -$34.1M to $8.68M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Esperion Therapeutics ESPR Change in AP

Change in AP at other companies

AmgenAMGN

$571M+14.9%

Regeneron PharmaceuticalsREGN

$107.7M+150%

NewAmsterdam Pharma CompanyNAMS

-$793K-135%

Lexicon PharmaceuticalsLXRX

-$6.9M+68.2%

Zevra Therapeutics, Inc.ZVRA

-$529K+92.7%

Eton Pharmaceuticals, Inc.ETON

$2.51M+256%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's change in AP?: Esperion Therapeutics (ESPR) reported change in AP of $3.34M in Q1 2026.
How has Esperion Therapeutics's change in AP changed year-over-year?: Esperion Therapeutics's change in AP decreased by 88.0% year-over-year, from $27.84M to $3.34M.
What is the long-term trend for Esperion Therapeutics's change in AP?: Over 2 years (2021 to 2023), Esperion Therapeutics's change in AP has grown at a -49.6% compound annual growth rate (CAGR), from -$34.1M to $8.68M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.